SCHEMBL64965

SCHEMBL64965

CCOC(=O)CCN

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL27485708 0.97 CYP1A2 (0.71)
Hydrochloric Acid SCHEMBL2988 0.97
SCHEMBL28630036 0.97
Hypochlorous Acid SCHEMBL9150736 0.95 CYP1A2 (0.68)
Hydrochloric Acid SCHEMBL2218353 0.95
SCHEMBL28147474 0.91 CYP1A2 (0.63)
Monoethanolamine SCHEMBL2583170 0.91 CYP1A2 (0.63)
Beta-Alanine SCHEMBL1878089 0.91 CYP1A2 (0.63)
Succinic Acid Diethyl Ester SCHEMBL7700334 0.90 CYP1A2 (0.74)
SCHEMBL4650134 0.89 CYP1A2 (0.61)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1501 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118668256-A Refining method for producing anode copper from black copper 江西省金瑞环保科技有限公司 2024-09-20 CN claimed
CN-115583908-B Indole carboxamide compound and preparation method and application thereof 西北农林科技大学 2024-08-06 CN claimed
CN-118256111-A UV resin-containing ink with excellent water resistance and preparation method thereof 英德市澳玛尔康高分子新材料有限公司 2024-06-28 CN claimed
CN-117924684-A Preparation method of amino-terminated polyether 山东隆华新材料股份有限公司 2024-04-26 CN claimed
CN-117510402-A Optimized dabigatran etexilate key intermediate synthesis process 江苏阿尔法药业股份有限公司 2024-02-06 CN claimed
EP-3666767-B1 PHTHALAZINONE DERIVATIVES, METHOD FOR THEIR PREPARATION THEREOF, PHARMACEUTICAL COMPOSITION COMPRISING THEM, AND THEIR USE SHANGHAI INST MATERIA MEDICA CAS (CN) 2021-12-01 EP claimed
US-11040952-B2 Phthalazinone compound, method for preparation thereof, pharmaceutical composition thereof, and use thereof SHANGHAI INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF SCIENCES (CN) 2021-06-22 US claimed
CN-109134429-B Phthalazinone compound, preparation method, pharmaceutical composition and application thereof 中国科学院上海药物研究所 2021-06-01 CN claimed
US-20200390100-A1 SUBSTITUTED N-HETEROCYCLYL- AND N-HETEROARYL-TETRAHYDROPYRIMIDINONES AND THE SALTS THEREOF, AND THE USE OF SAME AS HERBICIDAL ACTIVE SUBSTANCES BAYER AG (DE) 2020-12-17 US claimed
EP-3728214-A1 SUBSTITUTED N-HETEROCYCLYL- AND N-HETEROARYL-TETRAHYDROPYRIMIDINONES AND THE SALTS THEREOF, AND THE USE OF SAME AS HERBICIDAL ACTIVE SUBSTANCES Bayer Aktiengesellschaft (DE) 2020-10-28 EP claimed
US-5644059-A REACTION OF KETONE WITH ACRYLAMIDE AND AMMONIA OR AMMONIUM SALT FUJIREBIO INC. (JP) 1997-07-01 US claimed
WO-1997011060-A1 PYRAZIN-2-ONE DERIVATIVES, THEIR USE, AND INTERMEDIATES FOR THEIR PRODUCTION SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1997-03-27 WO claimed
EP-0591392-A1 PHARMACEUTICAL FORMULATIONS OF OSTEOGENIC PROTEINS. GENETICS INST (US) 1994-04-13 EP claimed
EP-0325245-B1 Phenoxyacetic acid derivatives, preparation thereof, pharmaceutical compositions comprising them and use TANABE SEIYAKU CO (JP) 1993-10-20 EP claimed
WO-1993000050-A1 PHARMACEUTICAL FORMULATIONS OF OSTEOGENIC PROTEINS GENETICS INSTITUTE, INC. (US) 1993-01-07 WO claimed
EP-0488345-A1 1,4-Dihydropyridine derivatives and methods of producing the same FUJIREBIO INC. (JP) 1992-06-03 EP claimed
US-5051446-A Cardiovascular disorders E. I. DU PONT DE NEMOURS & CO. (US) 1991-09-24 US claimed
EP-0415212-A1 Aryloxynaphthalene derivatives BAYER AG (DE) 1991-03-06 EP claimed
US-4443475-A ANTIARRHYTHMIA AGENTS, ANTIDEPRESSANTS CAVAZZA CLAUDIO (IT) 1984-04-17 US claimed
US-4069323-A INHIBITION AND SUPPRESSION OF THROMBOSIS MITSUBISHI CHEMICAL INDUSTRIES LTD. (JA) 1978-01-17 US claimed